Cargando…

lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration

OBJECTIVE: To investigate the relationship between the long noncoding RNA (lncRNA) Prostate cancer-associated transcription factors 14 (PCAT14) and the clinical characteristics of prostate cancer and immune cell infiltration. METHODS: The relationship between PCAT14 expression and the clinicopatholo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Yunkun, Liu, Jianjun, Xu, Zhijian, Ye, Mushi, Li, Jianchang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741340/ https://www.ncbi.nlm.nih.gov/pubmed/35003397 http://dx.doi.org/10.1155/2021/9494619

Ejemplares similares

The Role of lncRNA PCAT6 in Cancers
por: Wang, Siying, et al.
Publicado: (2021)

LncRNA PCAT-1 in gastrointestinal cancers: A meta-analysis
por: Liu, Wanwei, et al.
Publicado: (2018)

Inhibition of lncRNA PCAT19 promotes breast cancer proliferation
por: Feng, Jianyuan, et al.
Publicado: (2023)

LncRNA PCAT1 and its genetic variant rs1902432 are associated with prostate cancer risk
por: Yuan, Qinbo, et al.
Publicado: (2018)

LncRNA PCAT18 Promotes Non-Small Cell Lung Cancer Progression by Sponging miR-4319
por: He, Li, et al.
Publicado: (2021)

Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
por: Tang, Xiaomei, et al.
Publicado: (2022)

Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer()
por: Shukla, Sudhanshu, et al.
Publicado: (2016)

Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder Cancer
por: Yan, Yunkun, et al.
Publicado: (2022)

lncRNA-PCAT1 rs2632159 polymorphism could be a biomarker for colorectal cancer susceptibility
por: Yang, Ming-li, et al.
Publicado: (2019)

The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma
por: Zhang, Xuedong, et al.
Publicado: (2018)

Screening and verification of prognostic lncRNA markers related to immune infiltration in the metastasis of osteosarcoma
por: He, Chuan, et al.
Publicado: (2022)

LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer
por: Li, Chao, et al.
Publicado: (2021)

Knockdown of lncRNA PCAT1 Enhances Radiosensitivity of Cervical Cancer by Regulating miR-128/GOLM1 Axis
por: Ge, Xingping, et al.
Publicado: (2020)

Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis
por: Dong, Xiaoyan, et al.
Publicado: (2020)

LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex
por: Shang, Zhiqun, et al.
Publicado: (2019)

LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis
por: Zhao, Peng, et al.
Publicado: (2021)

Retracted: Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis
por: Markers, Disease
Publicado: (2023)

SMAD3/SP1 complex‐mediated constitutive active loop between lncRNA PCAT7 and TGF‐β signaling promotes prostate cancer bone metastasis
por: Lang, Chuandong, et al.
Publicado: (2020)

LncRNA PCAT-1 Promoted ESCC Progression via Regulating ANXA10 Expression by Sponging miR-508-3p
por: Zang, Bao, et al.
Publicado: (2019)

LncRNA PCAT6 Accelerates the Progression and Chemoresistance of Cervical Cancer Through Up-Regulating ZEB1 by Sponging miR-543
por: Ma, Zhongping, et al.
Publicado: (2020)

Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer
por: Hu, Wei, et al.
Publicado: (2021)

LncRNA PCAT-1 upregulates RAP1A through modulating miR-324-5p and promotes survival in lung cancer
por: Huang, Na, et al.
Publicado: (2019)

M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2
por: Dong, Fang, et al.
Publicado: (2020)

Baseline lncRNA PCAT1 high expression and its longitude increment during induction therapy predict worse prognosis in multiple myeloma patients
por: Zhao, Peng, et al.
Publicado: (2021)

LncRNA PCAT19 induced by SP1 and acted as oncogene in gastric cancer competitively binding to miR429 and upregulating DHX9
por: Xiao, Lei, et al.
Publicado: (2022)

m(6)A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
por: Lang, Chuandong, et al.
Publicado: (2021)

LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer
por: Ye, Ting, et al.
Publicado: (2021)

LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
por: Lin, Zhichao, et al.
Publicado: (2021)

LncRNA‐PCAT1 targeting miR‐145‐5p promotes TLR4‐associated osteogenic differentiation of adipose‐derived stem cells
por: Yu, Lingjia, et al.
Publicado: (2018)

Correction: M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2
por: Dong, Fang, et al.
Publicado: (2022)

LncRNA PCAT6 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of lung adenocarcinoma cell by targeting miR-545-3p
por: Yang, Chuyi, et al.
Publicado: (2023)

The PCAT3/PCAT9-miR-203-SNAI2 axis functions as a key mediator for prostate tumor growth and progression
por: Tao, Fangfang, et al.
Publicado: (2018)

lncRNA PCAT6 promotes non-small cell lung cancer cell proliferation, migration and invasion through regulating miR-330-5p
por: Cui, Li Hua, et al.
Publicado: (2018)

The Down-Regulation of lncRNA PCAT18 Promotes the Progression of Gastric Cancer via MiR-107/PTEN/PI3K/AKT Signaling Pathway
por: Chen, Ping, et al.
Publicado: (2019)

Knockdown of lncRNA PCAT6 Enhances Radiosensitivity in Triple-Negative Breast Cancer Cells by Regulating miR-185-5p/TPD52 Axis
por: Shi, Rui, et al.
Publicado: (2020)

lncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR-326/hnRNPA2B1 axis in liver cancer
por: Luo, Jun, et al.
Publicado: (2021)

LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway
por: Liu, Shi-Yuan, et al.
Publicado: (2021)

LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
por: Gao, Yanping, et al.
Publicado: (2022)

Corrigendum: LncRNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway
por: Tu, Jianfei, et al.
Publicado: (2021)

LncRNA FOXP4-AS1 Promotes Progression of Ewing Sarcoma and Is Associated With Immune Infiltrates
por: Xiong, Jiachao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7128oj23f078tokq77jonkha21